U.S. Markets open in 5 hrs 22 mins
  • S&P Futures

    3,634.00
    +1.25 (+0.03%)
     
  • Dow Futures

    29,991.00
    -7.00 (-0.02%)
     
  • Nasdaq Futures

    12,108.00
    +32.00 (+0.26%)
     
  • Russell 2000 Futures

    1,852.00
    +0.50 (+0.03%)
     
  • Crude Oil

    45.35
    +0.44 (+0.98%)
     
  • Gold

    1,807.80
    +3.20 (+0.18%)
     
  • Silver

    23.40
    +0.10 (+0.43%)
     
  • EUR/USD

    1.1912
    +0.0016 (+0.1310%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    21.65
    -1.01 (-4.46%)
     
  • GBP/USD

    1.3352
    -0.0007 (-0.0494%)
     
  • USD/JPY

    104.3900
    -0.0900 (-0.0861%)
     
  • BTC-USD

    19,068.68
    +214.70 (+1.14%)
     
  • CMC Crypto 200

    377.98
    +8.23 (+2.22%)
     
  • FTSE 100

    6,447.21
    +15.04 (+0.23%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

The Valens Company Commences Trading on the Toronto Stock Exchange

KELOWNA, BC , April 16, 2020 /CNW/ - Valens GroWorks Corp. (TSX:VLNS) (VLNCF) (the "Company", "Valens" or "The Valens Company"), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce its common shares and certain warrants have commenced trading on the Toronto Stock Exchange under the trading symbols "VLNS" and "VLNS.WT," at which time they were delisted from the TSX Venture Exchange.

The Valens Company (CNW Group/The Valens Company)
The Valens Company (CNW Group/The Valens Company)

About The Valens Company

The Valens Company is a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products. The Company is focused on being the partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and white label product development and manufacturing. Valens is the largest third-party extraction company in Canada with an annual capacity of 425,000 kg of dried cannabis and hemp biomass at our purpose-built facility in Kelowna, British Columbia which is in the process of becoming European Union (EU) Good Manufacturing Practices (GMP) compliant. The Valens Company currently offers a wide range of product formats, including tinctures, two-piece caps, soft gels, oral sprays and vape pens as well as beverages, concentrates, topicals, edibles, injectables, natural health products and has a strong pipeline of next generation products in development for future release. Finally, the Company's wholly-owned subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant-Based Science. The Company expects to formally change its name in due course. For more information, please visit http://thevalenscompany.com. The Company's investor deck can be found specifically at http://thevalenscompany.com/investors/.

Notice regarding Forward Looking Statements

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/the-valens-company-commences-trading-on-the-toronto-stock-exchange-301041608.html

SOURCE The Valens Company

Cision
Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2020/16/c2235.html